CEO Juho Jalkanen

Dr. Juho Jalkanen is an experienced clinician, scientist and biopharmaceutical industry executive with extensive leadership experience across key functional areas including operations, business development, clinical development, medical and regulatory affairs. As Chief Executive Officer he leads business strategy and daily operations for Faron. This includes oversight of academic and industry partnerships, resource prioritization and allocation, chemistry, manufacturing and controls, and driving performance measures.  
Dr. Jalkanen joined Faron in 2017 as Vice President, Business Development. In 2018 he became the Company’s Chief Development Officer. In that role he was responsible for translational and clinical studies as well as market research and valuation of research projects and clinical programs. He also served as Faron’s interim Chief Medical Officer in 2021 and was a member of Faron’s Board of Directors from 2013 – 2018.  
Dr. Jalkanen earned a Master´s degree in economics and business administration from the Turku School of Economics and both his M.D. and Ph.D. degrees from the University of Turku. He is a fully licensed general practitioner and specialist in vascular surgery.